Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
1.145
+0.005 (0.44%)
At close: Apr 15, 2025, 4:00 PM
1.150
+0.005 (0.44%)
After-hours: Apr 15, 2025, 6:22 PM EDT
Femasys Employees
As of December 31, 2024, Femasys had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees increased by 37 or 108.82% compared to the previous year.
Employees
71
Change (1Y)
37
Growth (1Y)
108.82%
Revenue / Employee
$22,945
Profits / Employee
-$265,023
Market Cap
31.09M
Employees Chart
FEMY News
- 19 days ago - Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations - GlobeNewsWire
- 4 weeks ago - Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain - GlobeNewsWire
- 4 weeks ago - Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach - GlobeNewsWire
- 7 weeks ago - Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials - GlobeNewsWire
- 2 months ago - Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices - GlobeNewsWire
- 2 months ago - Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control - GlobeNewsWire
- 3 months ago - Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment - GlobeNewsWire